Clinical Trials on MuSK Myasthenia Gravis in Norway

Total 7 results

Ra Pharmaceuticals, Inc.

Active, not recruiting

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT)

Generalized Myasthenia Gravis

United States, Canada, France, Germany, Italy, Japan, Norway, Poland, Spain, United Kingdom
Ra Pharmaceuticals, Inc.

Completed

Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE)

Myasthenia Gravis, Generalized

United States, Canada, France, Germany, Italy, Japan, Norway, Poland, Spain, United Kingdom
Nantes University Hospital

Not yet recruiting

Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure (AGORAC)

Organ Grafts

Norway, Spain, France
Haukeland University Hospital

Completed

New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression

Thyroid-Associated Ophthalmopathy

Norway
Haukeland University Hospital

Recruiting

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Thyroid-Associated Ophthalmopathy

Norway
Circassia Limited
Syneos Health; CIDAL

Completed

Grass Observational Study

Grass Allergy | Rhinoconjunctivitis

United States, Argentina, Chile
Stallergenes Greer

Completed

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Allergic Rhinitis Due to Grass Pollens

United States

3

Subscribe